IRWD
NASDAQ · Biotechnology
Ironwood Pharmaceuticals Inc
$3.54
+0.02 (+0.57%)
Open$3.59
Previous Close$3.52
Day High$3.65
Day Low$3.49
52W High$5.78
52W Low$0.62
Volume—
Avg Volume2.18M
Market Cap582.73M
P/E Ratio5.70
EPS$0.58
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+1,360.5% upside
Current
$3.54
$3.54
Target
$51.70
$51.70
$40.79
$51.70 avg
$62.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 299.12M | 333.54M | 73.58M |
| Net Income | 24.26M | 24.35M | 12.49M |
| Profit Margin | 8.1% | 7.7% | 17.0% |
| EBITDA | 101.39M | 107.40M | 23.02M |
| Free Cash Flow | — | — | 13.98M |
| Rev Growth | -10.3% | -10.3% | +11.9% |
| Debt/Equity | 0.61 | 0.61 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.89 | +0.06% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $351.43 | +1.27% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.16 | +0.09% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $475.20 | +1.45% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $623.43 | +0.87% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $294.06 | +2.04% | 64.3 | 37.13B |